Bank of Montreal’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $300K | Buy |
6,444
+132
| +2% | +$6.34K | ﹤0.01% | 2776 |
|
|
2026
Q1 | $326K | Buy |
6,312
+1,033
| +20% | +$52.6K | ﹤0.01% | 2622 |
|
|
2025
Q4 | $262K | Sell |
5,279
-79
| -1% | -$3.84K | ﹤0.01% | 2678 |
|
|
2025
Q3 | $256K | Sell |
5,358
-4,786
| -47% | -$193K | ﹤0.01% | 2625 |
|
|
2025
Q2 | $320K | Buy |
10,144
+475
| +5% | +$15.2K | ﹤0.01% | 2552 |
|
|
2025
Q1 | $317K | Buy |
9,669
+2,074
| +27% | +$73.5K | ﹤0.01% | 2481 |
|
|
2024
Q4 | $275K | Buy |
7,595
+473
| +7% | +$16.7K | ﹤0.01% | 2594 |
|
|
2024
Q3 | $219K | Sell |
7,122
-109,200
| -94% | -$3.41M | ﹤0.01% | 2986 |
|
|
2024
Q2 | $3.29M | Buy |
116,322
+109,088
| +1,508% | +$3.16M | ﹤0.01% | 1442 |
|
|
2024
Q1 | $249K | Buy |
7,234
+143
| +2% | +$4.26K | ﹤0.01% | 2906 |
|
|
2023
Q4 | $210K | Sell |
7,091
-20,342
| -74% | -$539K | ﹤0.01% | 3107 |
|
|
2023
Q3 | $802K | Buy |
27,433
+19,192
| +233% | +$584K | ﹤0.01% | 2173 |
|
|
2023
Q2 | $278K | Sell |
8,241
-105
| -1% | -$3.67K | ﹤0.01% | 3002 |
|
|
2023
Q1 | $306K | Sell |
8,346
-2,269
| -21% | -$87.2K | ﹤0.01% | 2773 |
|
|
2022
Q4 | $397K | Buy |
10,615
+4,445
| +72% | +$154K | ﹤0.01% | 2750 |
|
|
2022
Q3 | $210 | Sell |
6,170
-1,642
| -21% | -$53.4K | ﹤0.01% | 3182 |
|
|
2022
Q2 | $227 | Sell |
7,812
-8,184
| -51% | -$234K | ﹤0.01% | 3193 |
|
|
2022
Q1 | $519K | Buy |
15,996
+1,488
| +10% | +$45.6K | ﹤0.01% | 2803 |
|
|
2021
Q4 | $437K | Sell |
14,508
-3,751
| -21% | -$114K | ﹤0.01% | 2493 |
|
|
2021
Q3 | $492K | Sell |
18,259
-235
| -1% | -$6.31K | ﹤0.01% | 2891 |
|
|
2021
Q2 | $605K | Buy |
18,494
+2,488
| +16% | +$76.3K | ﹤0.01% | 2735 |
|
|
2021
Q1 | $450K | Sell |
16,006
-1,189
| -7% | -$33.3K | ﹤0.01% | 2704 |
|
|
2020
Q4 | $486K | Buy |
17,195
+7,317
| +74% | +$157K | ﹤0.01% | 2720 |
|
|
2020
Q3 | $204K | Sell |
9,878
-4,308
| -30% | -$97.8K | ﹤0.01% | 2737 |
|
|
2020
Q2 | $338K | Buy |
14,186
+4,199
| +42% | +$92.8K | ﹤0.01% | 2466 |
|
|
2020
Q1 | $171K | Sell |
9,987
-24,536
| -71% | -$516K | ﹤0.01% | 2393 |
|
|
2019
Q4 | $819K | Sell |
34,523
-4,089
| -11% | -$99.3K | ﹤0.01% | 2392 |
|
|
2019
Q3 | $1.06M | Sell |
38,612
-2,659
| -6% | -$78.8K | ﹤0.01% | 2049 |
|
|
2019
Q2 | $1.37M | Buy |
41,271
+1,299
| +3% | +$44.5K | ﹤0.01% | 1917 |
|
|
2019
Q1 | $1.4M | Sell |
39,972
-1,912
| -5% | -$71.1K | ﹤0.01% | 1873 |
|
|
2018
Q4 | $1.39M | Sell |
41,884
-674
| -2% | -$29K | ﹤0.01% | 1726 |
|
|
2018
Q3 | $2.14M | Sell |
42,558
-37,364
| -47% | -$1.85M | ﹤0.01% | 1635 |
|
|
2018
Q2 | $4.78M | Buy |
79,922
+42,138
| +112% | +$2.18M | ﹤0.01% | 1191 |
|
|
2018
Q1 | $1.73M | Sell |
37,784
-1,736
| -4% | -$72.4K | ﹤0.01% | 1623 |
|
|
2017
Q4 | $1.57M | Buy |
39,520
+735
| +2% | +$29K | ﹤0.01% | 1716 |
|
|
2017
Q3 | $1.55M | Sell |
38,785
-8,338
| -18% | -$361K | ﹤0.01% | 1752 |
|
|
2017
Q2 | $2.03M | Sell |
47,123
-20,488
| -30% | -$729K | ﹤0.01% | 1616 |
|
|
2017
Q1 | $2.12M | Sell |
67,611
-13,094
| -16% | -$351K | ﹤0.01% | 1499 |
|
|
2016
Q4 | $1.74M | Buy |
80,705
+72,251
| +855% | +$1.61M | ﹤0.01% | 1639 |
|
|
2016
Q3 | $209K | Sell |
8,454
-1,353
| -14% | -$30.6K | ﹤0.01% | 2448 |
|
|
2016
Q2 | $199K | Sell |
9,807
-2,201
| -18% | -$39K | ﹤0.01% | 2471 |
|
|
2016
Q1 | $183K | Sell |
12,008
-8,362
| -41% | -$109K | ﹤0.01% | 2511 |
|
|
2015
Q4 | $273K | Buy |
20,370
+3,621
| +22% | +$56K | ﹤0.01% | 2250 |
|
|
2015
Q3 | $235K | Buy |
16,749
+38
| +0.2% | +$707 | ﹤0.01% | 2187 |
|
|
2015
Q2 | $284K | Buy |
+16,711
| New | +$238K | ﹤0.01% | 2254 |
|
|
2014
Q3 | – | Sell |
-1,010
| Closed | -$11K | – | 4381 |
|
|
2014
Q2 | $11K | Buy |
1,010
+510
| +102% | +$4.54K | ﹤0.01% | 3836 |
|
|
2014
Q1 | $4K | Hold |
500
| – | – | ﹤0.01% | 3834 |
|
|
2013
Q4 | $4K | Buy |
+500
| New | +$3.5K | ﹤0.01% | 3569 |
|
|
2013
Q3 | – | Sell |
-1,550
| Closed | -$10.4K | – | 3936 |
|
|
2013
Q2 | $10K | Buy |
+1,550
| New | +$9.13K | ﹤0.01% | 3298 |
|
Other funds holding SUPN
VPM
AC
VCM
NAMI
SIMG
Bank of Montreal's SUPN Position: Q2 2026 in Review
Bank of Montreal increased its Supernus Pharmaceuticals (SUPN) stake by 2.1% in Q2 2026, buying an estimated $6.34K and bringing the position to 6,444 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #2776.
Bank of Montreal first reported a position in SUPN in Q2 2013 and has held it in 49 quarters since. The position peaked at $4.78M in Q2 2018. 311 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.
- Bank of Montreal held 6,444 shares of Supernus Pharmaceuticals worth $300K as of Q2 2026.
- Bank of Montreal bought 132 Supernus Pharmaceuticals shares in Q2 2026, an estimated $6.34K.
- Supernus Pharmaceuticals made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2776 holding.
- Bank of Montreal first reported a position in Supernus Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
- Bank of Montreal's Supernus Pharmaceuticals position peaked at $4.78M in Q2 2018.
- 311 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.